The US Food and Drug Administration (FDA) has cleared Novaliq’s Investigational New Drug (IND) application for NOV05, enabling the initiation of the EYETAC phase II clinical trial ( NCT07285070) in ...
Mounjaro’s typical starting dosage is 2.5 milligrams (mg) once per week for 4 weeks, after which your doctor may increase the dose to 5 mg per week if needed to manage blood sugar levels. The ...
For optometrists, 2026 provides ample opportunity to continue the charge in advancements in dry eye, artificial intelligence ...
The most common side effects you may experience with Mounjaro include nausea, vomiting, diarrhea, constipation, and stomach pain. Mounjaro carries a boxed warning (the most serious type of FDA warning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results